Residence Sydney Role Physicist Citizenship British, Australian Fields Prostate cancer | Spouse Sarah Lowe Doctoral advisor Tony Hey Name Anthony Lowe | |
 | ||
Born 16 March 1962 (age 62)
Mtarfa, Malta ( 1962-03-16 ) Institutions Prostate Cancer Foundation of Australia, Griffith Health Institute Known for Expertise in prostate cancer and PSA testing Institution Prostate Cancer Foundation of Australia Books Research, Awareness, Support: Ten Years of Progress in Prostate Cancer: Prostate Cancer Foundation of Australia 2012 Community Attitudes Survey Alma mater University of Cambridge, University of Southampton | ||
Associate Professor Anthony Peter Lowe (born 16 March 1962) is a British-Australian mathematical physicist and actuary. He is Chief Executive Officer at Prostate Cancer Foundation of Australia and a frequent media commentator on prostate cancer and prostate specific antigen (PSA) testing.
Contents
His current research interests are community attitudes towards prostate cancer and cancer survivorship, particularly the psychosocial and economic aspects of survivorship.
Life and career
Dr Lowe was born in Malta and educated at The Perse School Cambridge. He studied mathematics at the University of Cambridge, graduating in 1983 and completing his Master of Mathematics (Part III of the Mathematical Tripos) in 1984. He was elected a Scholar of Robinson College, Cambridge in July 1983.
In 1984 Dr Lowe moved to the University of Southampton where he completed his Doctor of Philosophy in theoretical physics.
After completing his PhD Dr Lowe joined consulting actuaries R Watson & Sons (now part of Willis Towers Watson) and trained as an actuary. He was made a Fellow of the Institute of Actuaries in 1990 and was appointed a Partner of R Watson & Sons in 1991.
In 1994 Dr Lowe moved to Sydney, Australia. Shortly after moving to Sydney he joined AMP Limited’s superannuation consulting business as Investment Consulting Practice Leader. Whilst at AMP Dr Lowe led an AusAID funded project advising the Kingdom of Tonga on reform of their Civil Service Pension Scheme. He was subsequently appointed Program Director of a business change program in partnership with Andersen Consulting (now Accenture) to reengineer AMP's corporate superannuation administration platform (people, processes and technology).
In 1998 Dr Lowe joined Mercer where he held a variety of senior executive roles. He was appointed a Worldwide Partner in 1998 and Executive Director of Mercer's Australian business in 2001. From 2002 to 2004 Dr Lowe was seconded to Mercer’s US business as US Benefits Administration Practice Leader based in Princeton, New Jersey. Dr Lowe’s ultimate role at Mercer was Asia-Pacific Business Group Leader, Mercer Wealth Solutions with responsibility for Mercer's benefits administration businesses in Australia, New Zealand and Hong Kong, including the Mercer Super Trust and Mercer Portfolio Service.
In 1999 Dr Lowe was made a Fellow of the Institute of Actuaries of Australia. He has been a member of the Leadership & Career Development and Public Policy Council Committees of Actuaries Institute (Institute of Actuaries of Australia) since 2011 and 2014 respectively.
In 2007 Dr Lowe decided to move to the non-profit sector and was appointed Chief Operating Officer at the National Breast Cancer Foundation. Whilst at the National Breast Cancer Foundation he led the design and implementation of the integrated website and customer relationship management systems for the Pink Ribbon Breakfast campaign and Register4, Australia's first online community for volunteer breast cancer research participants.
In March 2011 Dr Lowe was appointed Chief Executive Officer at Prostate Cancer Foundation of Australia. In this role he has pursued an agenda of ensuring its activities and programs are based on the latest available scientific and medical evidence. Under his leadership, and in partnership with Cancer Council Australia, Prostate Cancer Foundation of Australia has developed clinical practice guidelines on PSA testing and early management of test-detected prostate cancer with the aim of building consensus around PSA testing and bringing order to Australia’s de facto unorganised prostate cancer screening program. The guideline recommendations were approved by the Chief Executive Officer of the National Health and Medical Research Council on 2 November 2015 and were published on 20 January 2016. Dr Lowe has championed prostate cancer survivorship research in partnership with Griffith University, particularly the development of ProsCare, a psychological care model for men with prostate cancer and research into the financial implications of treatment for prostate cancer. He has also championed the development of resources and peer support groups to meet the particular needs of gay and bisexual men and men from culturally and linguistically diverse and Aboriginal and Torres Strait Islander communities with prostate cancer.
Dr Lowe is the nephew of biologist and ichthyologist Rosemary Lowe-McConnell.